-+ 0.00%
-+ 0.00%
-+ 0.00%

US Food and Drug Administration: The overall benefits of Novartis and Atvis's approved indications continue to outweigh their potential risks.

Zhitongcaijing·11/07/2026 01:33:07
Listen to the news
US Food and Drug Administration: The overall benefits of Novartis and Atvis's approved indications continue to outweigh their potential risks.